Incidence of ventricular tachyarrhythmias and clinical outcomes in primary prophylactic ICD patients in relation to localization of myocardial infarction

16 April 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Thomas Kleemann

Klinikum Ludwigshafen, Ludwigshafen (Germany)

8 More presentations in this session

Presentation thumbnail

Zero or minimal fluoroscopy catheter ablation: feasibility, efficacy, and safety results.

Doctor J. Melero Polo (Zaragoza, ES)

Abstract Slides

Presentation thumbnail

Ultrasound-guidance for femoral venipuncture reduces access site complications after ablation of atrial fibrillation and other left atrial tachycardias: a retrospective single- center analysis

Doctor P. Poley (Luebeck, DE)

Abstract Slides

Presentation thumbnail

Diagnostic gain of cardiac MR in patients with premature ventricular complexes and structurally normal hearts on echocardiography

Doctor T. Ahmed (Oslo, NO)

Abstract Slides

Presentation thumbnail

Update on rare variants in inherited arrhythmogenic syndromes: when to reclassify?

Miss E. Martinez Barrios (Barcelona, ES)

Abstract Slides

Presentation thumbnail

Familial cardiolaminopathy due to a previously undescribed LMNA gene mutation

Doctor R. Ibarra Castillo (Quito, EC)

Abstract Slides

Access the full session

Session thumbnail

ePoster session 47

The Event

Event poster

EHRA 2023

16 April - 18 April 2023

You may be interested in

Congress Presentation

Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

Congress Presentation

Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources